David Smelson to Buprenorphine
This is a "connection" page, showing publications David Smelson has written about Buprenorphine.
Connection Strength
0.525
-
Suzuki J, Martin B, Loguidice F, Smelson D, Liebschutz JM, Schnipper JL, Weiss RD. A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial. J Addict Med. 2023 Sep-Oct 01; 17(5):604-607.
Score: 0.165
-
Stimmel MA, Smelson D, Finlay AK. Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic. Psychiatr Serv. 2022 12 01; 73(12):1320-1321.
Score: 0.156
-
Taylor EN, Timko C, Binswanger IA, Harris AHS, Stimmel M, Smelson D, Finlay AK. A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Subst Abus. 2022; 43(1):556-563.
Score: 0.149
-
Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. J Subst Abuse Treat. 2018 12; 95:43-47.
Score: 0.030
-
Finlay AK, Harris AH, Rosenthal J, Blue-Howells J, Clark S, McGuire J, Timko C, Frayne SM, Smelson D, Oliva E, Binswanger I. Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug Alcohol Depend. 2016 Mar 01; 160:222-6.
Score: 0.025